Curing agents for epoxy resins

Information

  • Patent Grant
  • 8278396
  • Patent Number
    8,278,396
  • Date Filed
    Friday, May 13, 2011
    13 years ago
  • Date Issued
    Tuesday, October 2, 2012
    12 years ago
Abstract
A curing agent for epoxy resin has one or more five- or six-membered aromatic rings, and substituted on the one or more five- or six-membered rings at least two functionalities reactive with the epoxy selected from the group consisting of hydroxyl, amine, imidazole, azine, hydrazide, anhydride, and Lewis acid groups. Choice of functionality can provide a mixed polymer network, one with a more densely cross-linked polymer structure having a high Tg, and the other with a more linear polymer structure to contribute to stress reduction.
Description
BACKGROUND OF THE INVENTION

Epoxy resins are used as adhesives, coatings, and molding compounds in the manufacture of articles that undergo thermal cycling either during fabrication or operation.


Two common curing agents for epoxy resins are aromatic amines or phenols. Aromatic amine curing agents give higher cross-link density, and consequently higher Tg values than phenol curing agents. It would be desirable to have a curing agent for epoxy resins that give a balance of properties to the cured epoxy.


SUMMARY OF THE INVENTION

This invention is a curable composition comprising an epoxy resin and a curing agent for the epoxy resin that has two or more different functionalities, both reactive with epoxy. The functionalities are those that can either react and form covalent bonds with the epoxy or accelerate the epoxy curing reaction. The presence of the two or more different functionalities on the curing agent will cause the formation of mixed epoxy polymer networks, which can enhance the physical and mechanical properties of the cured epoxy.







DETAILED DESCRIPTION OF THE INVENTION

The curing agent will be a compound having one or more five- or six-membered aromatic rings, and substituted on the one or more five- or six-membered rings at least two functionalities selected from the group consisting of hydroxyl, amine, imidazole, azine, hydrazide, anhydride, and Lewis acid groups. The five- or six-membered aromatic ring optionally may contain heteroatoms (nitrogen or sulfur); optionally may be fused to one or more other aromatic or aliphatic cyclic rings; and optionally may contain an electron-withdrawing or electron-donating group.


Exemplary structures of these curing agents include




embedded image


in which f1 and f2 independently are selected from the group consisting of hydroxyl, amine, azine, hydrazide, anhydride, imidazole or Lewis acid, provided that f1 and f2 are different; (the repeating aryl rings in the first structure, non-fused, connected by R, can be connected at the ortho, meta, or para positions on the benzene ring);


n and m independently are numerals from 0 to 4, provided that when n is 0, x is at least 1;


x is a numeral from 0 to 100, preferably 0 to 20, provided that when x is 0, n is at least 1 and R1 is f2;


R is a monovalent or polyvalent radical, which includes hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, polysiloxanes, polysiloxane-polyurethane block copolymers, and combinations of any of the above linked with one or more linking groups selected from the group consisting of a covalent bond, —O—, —S—, —NR3—, —O—C(O)—, —O—C(O)—O—, —O—C(O)—NR3—, —NR3—C(O)—, —NR3—C(O)—NR3—, —N═N—, —S—C(O)—,




embedded image



in which R3 is independently for each position selected from the group consisting of hydrogen, alkyl, alkylene, alkoxy, acrylate, aryl, and maleimide;


R1 and R2 independently are selected from the group consisting of —R, —H, —CH3, —OCH3, —O(CH2)nCH3, —(CH2)nf3 in which n is a numeral from 1 to 20 and f3 is a hydrocarbyl group containing at least one carbon to carbon unsaturated bond (e.g. a vinyl group, and allyl group, an aryl group);




embedded image



in which R3 independently for each position is selected from the group consisting of hydrogen, alkyl, alkylene, alkoxy, acrylate, aryl, and maleimide; provided that when x is 0, R1 is f1.


The functionalities are chosen so that one will provide a densely cross-linked and high Tg polymer network, and the other a less densely cross-linked and lower Tg polymer network. This combination will provide both strength and toughness (flexibility) in the cured composition.


The introduction of bulky side chains, R1 and R2, on the exemplary structures can increase steric hindrance and thus reduce reactivity and improve the pot life of the formulation. One example of this is depicted in the following reaction scheme:




embedded image


In another embodiment, to further reduce reactivity, a bulky side chain with a carbonyl group can be introduced to stabilize the transition state of the reaction intermediate. This is depicted in the following reaction scheme:




embedded image


In one embodiment, the curing agents have both amine and phenol functionality. The amine and phenol functionalities work simultaneously to increase cure speed and give balanced performance to the cured adhesive. The amine-cured epoxy component gives a more densely cross-linked, and consequently higher Tg, polymer network than the phenol-cured epoxy component. The phenol-cured epoxy component provides a more linear polymer structure, which contributes to stress reduction.


Particular curing agents are selected from the group consisting of




embedded image


in which R1 and R2 independently are selected from the group consisting of —H; —CH3; —OCH3; —O(CH2)nCH3;


and —(CH2)nf3, in which n is a numeral from 1 to 20, preferably 1 to 10, and f3 is a hydrocarbyl group containing at least one vinyl functionality;


and




embedded image



in which R3 independently for each position is selected from the group consisting of hydrogen, alkyl, alkylene, alkoxy, acrylate, aryl, and maleimide;


and in which R4 is selected from the group consisting of




embedded image



and —(CH2)n—, in which n is a numeral from 1 to 6.


Suitable epoxy resins for formulating the curable compositions include bisphenol, naphthalene, and aliphatic type epoxies. Commercially available materials include bisphenol type epoxy resins (Epiclon 830LVP, 830CRP, 835LV, 850CRP) available from Dainippon Ink & Chemicals, Inc.; naphthalene type epoxy resins (Epiclon HP4032) available from Dainippon Ink & Chemicals, Inc.; aliphatic epoxy resins (Araldite CY179, 184, 192, 175, 179) available from Ciba Specialty Chemicals, (Epoxy 1234, 249, 206) available from Dow, and (EHPE-3150) available from Daicel Chemical Industries, Ltd. Other suitable epoxy resins include cycloaliphatic epoxy resins, bisphenol-A type epoxy resins, bisphenol-F type epoxy resins, epoxy novolac resins, biphenyl type epoxy resins, naphthalene type epoxy resins, and dicyclopentadienephenol type epoxy resins.


The stoichiometric ratio of amine curing agent to epoxy resin should be as close to 1:2 as possible to form a highly cross-linked, dense polymer network. The stoichiometric ratio of phenol curing agent to epoxy should be as close to 1:1 as possible to form a low cross-linked, non-dense polymer network.


In some compositions it may be desirable to include a filler. Suitable nonconductive fillers include silica, calcium carbonate, mica, titania, sand, glass, and polymer fillers. When included, fillers will be present in amounts of 10˜90% by weight of the formulation.


Sample formulations include those disclosed in the following table.














SAMPLE















1
2
3
4
5
6
7


Ingredient
wt %
wt %
wt %
wt %
wt %
wt %
wt %

















Allyl phenol
43.82








REZICURE 3700 SI









Group









3,3′-Diaminodiphenyl

24.04







sulfone (Chriskev Co.)









5-Amino-1-naphenol


21.30






2-Aminophenol



15.62





4-Aminophenol




15.62




3-Aminophenol





15.62



5-Amino-2-






19.24


methoxyphenol









Bisphenol F
56.18
75.96
78.70
84.38
84.38
84.38
80.76


Diglycidyl Ether









Dainippon Ink &









Chem.









Total weight percent
100.00
100
100.00
100.00
100.00
100.00
100.00









EXAMPLES

The compounds used in the Examples were purchased from Aldrich, with the exception that 1-[(2-methyl-1H-imidazole-1yl)methyl]-2-naphthalenol was purchased from Huntsman. The compounds have the following structures:




embedded image


embedded image


Example 1

Compositions were prepared to have the components shown in Table 1. Diglycidyl ether bisphenol F was employed as the epoxy resin in all compositions. Composition A contained an aromatic amine as the cure agent; composition B contained a phenol as the cure agent. Compositions C to H contained hybrid curing agents in accordance with the invention. The compositions were subjected to Differential Scanning calorimetry (DSC) to effect cure and the temperatures for cure onset, cure peak, and cure exotherm reported. All compositions exhibited exothermal reactions.

















TABLE 1






A
B
C
D
E
F
G
H



wt %
wt %
wt %
wt %
wt %
wt %
wt %
wt %















EPOXY RESIN















diglycidyl ether
56
75.6
78.4
82.5
95.2
97.1
66.0
79.2


bisphenol F















Curing Agent















diallyl bis-A
44









phenol










3,3-diamino-

24.4








diphenyl










sulfone










5-amino-1-


21.6







naphenol










2-amino-3-



17.5






methyl-phenol










1-[(2-methyl-




4.8





1H-imidazole-










1yl)methyl]-2-










naphthalenol










2-amino-1-





2.9




methyl-










benzimidazole










3-hydroxy-2-






33.4



methyl-4-










quinoline-










carboxylic acid










3-hydroxy-2-







20.8


naphthoic










hydrazide










Total
100
100
100
100
100
100
100
100







DSC RESULTS















onset (° C.)
195
105
95
73
135
166
162
144


1st peak temp
274
212
123
114
146
296
180
162


DELTA H
173
361
254
237
319
171
232
186


(J/G)









Example 2

The stoichiometric ratio of curing agent to Bis-F epoxy resin was calculated for the curing agents in Example 1, shown in Table 2.














TABLE 2





EXAMPLE 1 FORMULATION

HEW





CURING AGENTS WITH

OR
TOTAL
MOLE
WEIGHT


BIS-F EPOXY RESIN
WEIGHT
EEW
MOLE
RATIO
%




















A: diallyl bisphenol A
31.5
152
0.207
0.881
44.056


B: diaminodiphenyl sulfone
12.9
62
0.208
0.884
24.386


C: 5-amino-1-naphenol
11
53
0.208
0.882
21.569


D: 2-Amino-3-methylphenol
8.5
41.05
0.207
0.880
17.526


E: 1-[(2-methyl-1H-imidazole-
2
250
0.008
0.034
4.762


1yl)methyl]-2-naphthalenol


F: 2-amino-1-methylbenz-
1.2
147.18
0.008
0.032
2.913


imidazole


G: 3-hydroxy-2-methyl-4-
21.1
101.95
0.207
0.880
33.977


quinolinecarboxylic acid


H: 3-hydroxy-2-naphthoic
10.5
50.55
0.208
0.883
20.792


hydrazide


Bis F epoxy resin
40
170
0.235
1.000









Example 3

A curing agent, 5-amino-1-naphthenol, was used to cure various epoxy compounds, in a molar ratio of curing agent to epoxy of 0.9:1, using DSC. The DSC results are reported in Table 3.











TABLE 3






HEW/



Component
EEW
WEIGHT RATIO




















5-amino-1-naphenol
53
11.00
11.00
11.00
11.00


(curing agent)


Bis-F epoxy
170
40.00


EPICLON EXA-830


linear aliphatic
104

24.44


epoxy


(78-4574)


naphthalene epoxy
143


33.65


(HD4032)(RE1840)


novolac epoxy
176



41.41


EPICLON EXA-730A









Mole Ratio curing

0.9


agent to epoxy







DSC RESULTS











onset (° C.)
99
79
100
110


first peak temp
127
119
117
123


DELTA H (J/G)
250
295
196
205








Claims
  • 1. A curable composition comprising an epoxy resin and a curing agent for the epoxy resin that has the structure
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of International Patent Application No. PCT/US2009/064929 filed Nov. 18, 2009, which claims the benefit of U.S. Provisional Patent Application No. 61/116,328 filed Nov. 20, 2008, the contents of both of which are incorporated herein by reference.

Foreign Referenced Citations (4)
Number Date Country
10265549 Oct 1998 JP
2006137822 Jun 2006 JP
2007056152 Mar 2007 JP
0188034 Nov 2001 WO
Related Publications (1)
Number Date Country
20110213096 A1 Sep 2011 US
Provisional Applications (1)
Number Date Country
61116328 Nov 2008 US
Continuations (1)
Number Date Country
Parent PCT/US2009/064929 Nov 2009 US
Child 13106924 US